These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22578373)

  • 61. Universal WBC reduction.
    Nightingale SD;
    Transfusion; 2001 Oct; 41(10):1306-9. PubMed ID: 11606833
    [No Abstract]   [Full Text] [Related]  

  • 62. Increasing compliance with institutional guidelines for fresh-frozen plasma transfusions.
    Holland LL; Brooks JP
    Transfusion; 2007 Nov; 47(11):2169-70; author reply 2170. PubMed ID: 17958547
    [No Abstract]   [Full Text] [Related]  

  • 63. Conventional blood banking and blood component storage regulation: opportunities for improvement.
    Hess JR
    Blood Transfus; 2010 Jun; 8 Suppl 3(Suppl 3):s9-15. PubMed ID: 20606757
    [No Abstract]   [Full Text] [Related]  

  • 64. [Rational blood component therapy in patients with life-threatening hemorrhage].
    Johansson PI; Lethagen S; Lippert FK; Stensballe J;
    Ugeskr Laeger; 2005 Jun; 167(25-31):2753-5. PubMed ID: 16014258
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Quality standards and quality control of plasma].
    Fürst G
    Beitr Infusionsther; 1991; 28():49-55. PubMed ID: 1725660
    [No Abstract]   [Full Text] [Related]  

  • 66. AIDS row closes German health office.
    Karcher HL
    BMJ; 1993 Oct; 307(6911):1023. PubMed ID: 8251775
    [No Abstract]   [Full Text] [Related]  

  • 67. Public policy, blood safety and haemovigilance.
    Roberts DJ
    Transfus Med; 2011 Dec; 21(6):357-8. PubMed ID: 22082175
    [No Abstract]   [Full Text] [Related]  

  • 68. Transfusion-related acute lung injury: reports to the French Hemovigilance Network 2007 through 2008.
    Ozier Y; Muller JY; Mertes PM; Renaudier P; Aguilon P; Canivet N; Fabrigli P; Rebibo D; Tazerout M; Trophilme C; Willaert B; Caldani C
    Transfusion; 2011 Oct; 51(10):2102-10. PubMed ID: 21382042
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Leukodepleted blood components: definition of a standard.
    Andreu G; Masse M; Royer SD; Tardivel R
    Transfus Sci; 1998 Dec; 19(4):381-3. PubMed ID: 10351163
    [No Abstract]   [Full Text] [Related]  

  • 70. Conference report: the 2015 SHOT symposium and report--what's new?
    Bolton-Maggs PH
    Transfus Med; 2015 Oct; 25(5):295-8. PubMed ID: 26498582
    [No Abstract]   [Full Text] [Related]  

  • 71. The management of blood safety in the presence of uncertain risk: a United kingdom perspective.
    Watkins NA; Dobra S; Bennett P; Cairns J; Turner ML
    Transfus Med Rev; 2012 Jul; 26(3):238-51. PubMed ID: 22126710
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The American Red Cross Hemovigilance Program: advancing the safety of blood donation and transfusion.
    Eder AF; Dy BA; Barton J; Kennedy JM; Benjamin RJ
    Immunohematology; 2009; 25(4):179-85. PubMed ID: 20406027
    [No Abstract]   [Full Text] [Related]  

  • 73. The administration of blood components: a British Society for Haematology Guideline.
    Robinson S; Harris A; Atkinson S; Atterbury C; Bolton-Maggs P; Elliott C; Hawkins T; Hazra E; Howell C; New H; Shackleton T; Shreeve K; Taylor C
    Transfus Med; 2018 Feb; 28(1):3-21. PubMed ID: 29110357
    [No Abstract]   [Full Text] [Related]  

  • 74. General principles of small animal blood component administration.
    Kristensen AT; Feldman BF
    Vet Clin North Am Small Anim Pract; 1995 Nov; 25(6):1277-90. PubMed ID: 8619266
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Therapy with blood components and plasma derivatives: the current cross-sectional guidelines].
    Biscoping J
    Anaesthesist; 2009 Nov; 58(11):1083-4. PubMed ID: 19890616
    [No Abstract]   [Full Text] [Related]  

  • 76. Blood safety.
    Mant S; Smith MP
    N Z Med J; 2013 May; 126(1374):10-1. PubMed ID: 23799377
    [No Abstract]   [Full Text] [Related]  

  • 77. Research opportunities in optimizing storage of red blood cell products.
    Wagner SJ; Glynn SA; Welniak LA;
    Transfusion; 2014 Feb; 54(2):483-94. PubMed ID: 23676138
    [No Abstract]   [Full Text] [Related]  

  • 78. Pathogen reduced plasma products: a clinical practice scientific review from the AABB.
    Cushing MM; Pagano MB; Jacobson J; Schwartz J; Grossman BJ; Kleinman S; Han MA; Cohn CS;
    Transfusion; 2019 Sep; 59(9):2974-2988. PubMed ID: 31268584
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The potential for bacterial testing of blood products.
    Wagner SJ
    Zentralbl Bakteriol; 1996 Mar; 283(3):253-7. PubMed ID: 8861862
    [No Abstract]   [Full Text] [Related]  

  • 80. Managing recalls and withdrawals of blood components.
    Ramsey G
    Transfus Med Rev; 2004 Jan; 18(1):36-45. PubMed ID: 14689376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.